NCT06038994View on ClinicalTrials.gov

Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2025

Conditions
Myocardial Infarction, Acute
Interventions
OTHER

No intervention

This is an obvertional study, and there is no intervention.

Trial Locations (1)

223300

RECRUITING

Huai'an First People's Hospital, Huai'an

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT06038994 - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter